SmPC - Propafenone hydrochloride 300mg Film-coated Tablets: Change history
View Summary of Product Characteristics (SmPC - Propafenone hydrochloride 300mg Film-coated Tablets)
Last updated on this site: 17 Feb 2023
Description of update: Type II (C.I.2.b) To update the SPC and PIL in-line with reference product (Rytmonorm SR 225 mg Hartkapseln, retardiert, MAH: Mylan Products Ltd, Procedure Number: DE/H/3854/001)
SmPC sections updated: 4.8, 10.
View Summary of Product Characteristics (SmPC - Propafenone hydrochloride 300mg Film-coated Tablets)
Last updated on this site: 17 Feb 2023
Description of update: Type II (C.I.2.b) To update the SPC and PIL in-line with reference product (Rytmonorm SR 225 mg Hartkapseln, retardiert, MAH: Mylan Products Ltd, Procedure Number: DE/H/3854/001)
SmPC sections updated: 4.8, 10.
-
Changes: (Updated: 17 Feb 2023)
Description of update: Type II (C.I.2.b) To update the SPC and PIL in-line with reference product (Rytmonorm SR 225 mg Hartkapseln, retardiert, MAH: Mylan Products Ltd, Procedure Number: DE/H/3854/001)
SmPC sections updated: 4.8, 10.
-
Changes: (Updated: 06 Dec 2022)
Section 4.8 - addition of “Acute generalized exanthematous pustulosis”
-
Changes: (Updated: 09 Nov 2022)
Updated
-
Changes: (Updated: 21 Sep 2022)
Initial upload